General
Oxford-AstraZeneca, local COVID vaccines given urgent approval in India
The head of India’s drugs regulator said he had given final approval for the emergency use of two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech.
Key points:
- India’s pharmaceutical regulator approved two COVID-19 vaccines simultaneously
- The Australian Government has ordered 50 million doses of the Oxford-AstraZeneca vaccine
- India’s first round of vaccinations aims to immunise 300 million people against coronavirus
The overall efficacy of the Oxford-AstraZeneca vaccine was 70.42 per cent, while Bharat Biotech’s COVAXIN was “safe and provides a robust immune response”, Drugs Controller General of India, Venugopal G Somani, said.
The British-developed Oxford-AstraZeneca…
-
General5 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business5 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General8 hours agoAlbanese beats drum on economy as trade clouds gather
-
General7 hours agoToo skewed, too gentlemanly | The Spectator Australia